corresponding period last year, or 36.62% increased, which was better than the average growth rate of industry. These are because of our correct expanding strategy that emphasized on real demand segment, and
corresponding period last year, or 45.30% increased. The increment was in accordance with company’s expanding strategy and management; therefore, company’s revenues were able to growth more than overall of
% as follows. 1. Revenue from sales In Q2/2018, the company’s revenue from sale was 1,119.65 million baht increased from 882.69 million baht showed in the corresponding period last year, or 26.84
third quarter of year 2018 compared to the same period of prior year and the prior period are as follows; For the three-month period, the Group reported total revenues (excluded other revenues) at THB
, due to additional administrative expense from expanding in MDF second line production. Financial cost of six-months and 2nd quarter on year 2018 decreased 98.89 and 98.60 percent from the same period
follows. 1. Revenue from sales In 2017, the company’s revenue from sale was 3,589.20 million baht increased by 882.13 million baht from the corresponding period last year, or 32.59% increased. The increment
. Administrative expenses on nine-month and 3nd quarter of 2019 decreased 25.90 and 18.22 percent from the same period of last year, due to additional administrative expenses from expanding in 2nd production line
. Administrative expenses on six-month and 2nd quarter of 2019 decreased 29.92 and 31.23 percent from the same period of last year, due to additional administrative expenses from expanding in 2nd production line was
ที ่B52-2020-08/001 14 August 2020 Subject: Management Discussion and Analysis - for the three-month period ended 30 June 2020 To: The President of Stock Exchange of Thailand B-52 Capital Public
period at the previous year. The Company plans to improve and increase the sales team to increase sales efficiency in distributor of medical devices and equipment business, expanding the existing customer